Clinical Lymphoma, Myeloma and Leukemia, 22(7), 483-494. Cancer Media Group Clinical Lymphoma, Myeloma and Leukemia, 22(7), 483-494. CIG MEDIA GROUP, LP Clinical Lymphoma Myeloma & Leukemia r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol instname Schuster, M, Zijlstra, J, Casasnovas, R-O, Vermaat, J S P, Kalakonda, N, Goy, A, Choquet, S, Neste, E V D, Hill, B, Thieblemont, C, Cavallo, F, de la Cruz, F, Kuruvilla, J, Hamad, N, Jaeger, U, Caimi, P, Gurion, R, Warzocha, K, Bakhshi, S, Sancho, J-M, Follows, G, Egyed, M, Offner, F, Vassilakopoulos, T, Samal, P, Ku, M, Ma, X, Corona, K, Chamoun, K, Shah, J, Shacham, S, Kauffman, M G, Canales, M & Maerevoet, M 2022, ' Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL) : A Post-hoc Analysis of the SADAL Study ', Clinical Lymphoma, Myeloma and Leukemia, vol. 22, no. 7, pp. 483-494 . https://doi.org/10.1016/j.clml.2021.12.016 Clinical lymphoma, myeloma & leukemia, Vol. 22, no.7, p. 483-494 (2022)
Clinical Lymphoma Myeloma & Leukemia r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol instname Clinical lymphoma, myeloma & leukemia, Vol. 22, no.1, p. 24-33 (2022) Clinical Lymphoma, Myeloma and Leukemia, 22(1), 24-33. CIG MEDIA GROUP, LP
The Lancet Haematology, 7(7), e511-e522. Lancet Publishing Group Kalakonda, N, Maerevoet, M, Cavallo, F, Follows, G, Goy, A, Vermaat, J S P, Casasnovas, O, Hamad, N, Zijlstra, J M, Bakhshi, S, Bouabdallah, R, Choquet, S, Gurion, R, Hill, B, Jaeger, U, Sancho, J M, Schuster, M, Thieblemont, C, De la Cruz, F, Egyed, M, Mishra, S, Offner, F, Vassilakopoulos, T P, Warzocha, K, McCarthy, D, Ma, X, Corona, K, Saint-Martin, J R, Chang, H, Landesman, Y, Joshi, A, Wang, H, Shah, J, Shacham, S, Kauffman, M, Van Den Neste, E & Canales, M A 2020, ' Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL) : a single-arm, multinational, multicentre, open-label, phase 2 trial ', The Lancet Haematology, vol. 7, no. 7, pp. e511-e522 . https://doi.org/10.1016/S2352-3026(20)30120-4 Lancet Haematology r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol instname